Compliance + Competitor Watch — ElloClinic, London

A real-time compliance (ASA/CAP + MHRA) and competitor audit of UK aesthetic-clinic advertising for ElloClinic (target area: London), generated from live Meta Ad Library creatives.

Where you're exposed

R1 — ElloClinic (HIGH Severity)

Direct promotion of Prescription-Only Medicines (POM). Ad copy lists 'anti-wrinkle injections' alongside dermal fillers and other treatments, violating the strict ASA/MHRA ban on advertising POMs to the public.

Recommended fix: Remove all references to 'anti-wrinkle injections' (and other tox euphemisms) from paid advertising. Reframe as 'consultations for fine lines and wrinkles' without mentioning the injectable solution.

View evidence

Rivals winning

Clinical Best Practice / Overcoming R6 — Alta Medispa (LOW Severity)

Exemplary clinical governance and risk transparency. Ad prominently highlights practitioner GMC-registration, CQC regulation, an 18+ age restriction, and clearly lists potential side effects (swelling, bruising, tenderness).

Recommended fix: Adopt a rigorous 'medical-first' tone in all ads. Include mandatory side-effect disclaimers, regulator mentions, and practitioner credentials to build trust and demonstrate safety compliantly.

View evidence

Your opening

R6 — Good Genetics Aesthetics (MED Severity)

Potentially misleading safety/comfort claims. Ad claims 'Pain level: minimal', which risks trivializing a medical procedure and bordering on a breach of rules against minimizing side effects or pain.

Recommended fix: Differentiate by running highly transparent campaigns that treat aesthetic procedures with medical seriousness, emphasizing thorough pre-treatment consultations rather than promising minimal pain.

View evidence

Ranked moves

1. Immediate POM Purge (R1) — Halt all active ads mentioning 'anti-wrinkle injections'. Replace the treatment-list format with a 'consultation-first' approach to comply with MHRA rules and prevent platform bans.
2. Deploy 'Medical-First' Disclaimers (Clinical Best Practice / Overcoming R6) — Enhance ad copy by embedding clinical governance markers (e.g., practitioner qualifications, mandatory side-effect awareness, age limits). This builds the high-trust authority that competitors like Alta Medispa are successfully leveraging.
3. Capitalize on Medical Transparency (R6) — Where competitors try to downplay discomfort or risks to drive conversions, lean into absolute clinical transparency. Position ElloClinic as a safer, more medically sound alternative for discerning patients.

Provenance — sources analyzed

• https://www.facebook.com/ads/library/?id=1287576476146334
• https://www.facebook.com/ads/library/?id=4236730193214121
• https://www.facebook.com/ads/library/?id=1273726861605840
• https://www.facebook.com/ads/library/?id=2247580022422233

---

Powered by Senso — your AI-searchable knowledge base.